[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1981

Origin of Plasma Protoporphyrin in Patients With Erythropoietic Protoporphyria

Arch Dermatol. 1981;117(9):526. doi:10.1001/archderm.1981.01650090006007
Abstract

To the Editor.—  In their reply to our communication in the August 1980 Archives (116:863-864), Poh-Fitzpatrick and Mathews-Roth still insist that the studies of Piomelli et al1 were partly in vivo. To resolve this semantic discordance, we will present our concept of an in vivo biochemical experiment. We visualize (at least) the following two broad types of study: (1) Collect specimens from a live animal, make the animal undergo stress, and collect specimens at recorded intervals. The specimens are then analyzed for a metabolite of interest to determine the effect of the experimental stress on turnover of the metabolite. (2) Administer radiotracers to a live animal, collect specimens, and monitor the rise and fall of radioactivity in a metabolite of interest. This type of experiment was conducted by Scholnick et al2 and by Schwartz et al3 to monitor protoporphyrin (PP) turnover in patients with erythropoietic protoporphyria (EPP).

First Page Preview View Large
First page PDF preview
First page PDF preview
×